tiprankstipranks
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
US Market
SCNI
Scinai Immunotherapeutics
RESEARCH TOOLSreports

Scinai Immunotherapeutics (SCNI) Income Statement

335 Followers

Scinai Immunotherapeutics Income Statement

Last quarter (Q2 2025), Scinai Immunotherapeutics's total revenue was $386.50K, an increase of 36.09% from the same quarter last year. In Q2, Scinai Immunotherapeutics's net income was $-2.07M. See Scinai Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Dec 21
Total Revenue
$ 1.31M$ 658.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.65M$ -580.00K$ -512.67K$ -559.80K$ -747.65K
Operating Expenses
$ 4.89M$ 8.06M$ 9.71M$ 11.06M$ 10.86M
Depreciation and Amortization
$ 1.42M$ 1.65M$ 514.00K$ 562.00K$ 471.00K
EBITDA
$ -6.53M$ -6.99M$ -9.19M$ -10.50M$ -10.39M
Operating Income
$ -7.54M$ -8.64M$ -9.71M$ -11.06M$ -10.87M
Other Income/Expenses
$ -765.00K$ 13.43M$ 3.21M$ 5.26M$ 2.67M
Pretax Income
$ -8.31M$ 4.80M$ -6.50M$ -5.80M$ -8.21M
Net Income
$ -8.31M$ 4.80M$ -6.50M$ -5.80M$ -8.21M
Per Share Metrics
Basic EPS
$ -3.60$ 6.00$ -16.80$ -30.80$ -80.00
Diluted EPS
$ -3.60$ 6.00$ -16.80$ -30.80$ -80.00
Weighted Average Shares Outstanding
 2.33M 806.37K 390.66K 188.52K 102.57K
Weighted Average Shares Outstanding (Diluted)
 2.33M 806.37K 390.66K 188.52K 141.14K
Currency in USD

Scinai Immunotherapeutics Earnings and Revenue History